1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Graft Rejection: new trials by email Literature Review of Graft Rejection trials Research Report on Graft Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation plasmapheresis and IVIG, recombinant C1 inhibitor - Graft Rejection, Kidney Transplantation | Phase 2 | Withdrawn | Pharming Technologies B.V. | 2010-12-01 | 2012-02-17 |
Immunoglobulins, Intravenous (1) · Plasmapheresis (1) · conestat alfa (1)
Pharming Technologies B.V. (1)
United States (1)